Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly

Endocrine Journal - Japan
doi 10.1507/endocrj.ej15-0619
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Endocrine Society

Related search

Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2007English

Glucose Homeostasis and Safety in Patients With Acromegaly Converted From Long-Acting Octreotide to Pegvisomant

Journal of Clinical Endocrinology and Metabolism
BiochemistryEndocrinologyClinical BiochemistryMedicineMetabolismDiabetes
2005English

Efficacy and Safety of Growth Hormone Replacement Therapy in Japanese Adults With Growth Hormone Deficiency: A Post-Marketing Observational Study

Endocrine Journal
EndocrinologyMetabolismDiabetes
2013English

Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY.

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2018English

Clinical Efficacy of Tolterodine for Patients With Overactive Bladder After Insufficient Efficacy by Monotherapy With .Alpha.1-Adrenoceptor Antagonist

Japanese Journal of Urology
Urology
2009English

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

Modern Rheumatology
MedicineRheumatology
2014English

What Is the Efficacy of Switching to Weekly Pegvisomant in Acromegaly Patients Well Controlled on Combination Therapy?

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2016English

Romiplostim Monotherapy in Thrombocytopenic Patients With Myelodysplastic Syndromes: Long-Term Safety and Efficacy

British Journal of Haematology
Hematology
2017English

Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening

Endocrine Abstracts
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy